TREDJE AP-FONDEN Edwards Lifesciences Corporation Transaction History

TREDJE AP-FONDEN portfolio value:

$5.11M
portfolio value

TREDJE AP-FONDEN quarter portfolio value change:

-13.10%
quarter

Edwards Lifesciences Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -46.00% -52.73K shares -5.78M $82.63 61.90K
Q2 2022 share 0.00% 0 shares -2.59M $95.09 114.63K
Q1 2022 share Increase +27.04% 24.4K shares 1.80M $117.72 114.63K
Q4 2021 share Increase +10.05% 8.23K shares 2.40M $130.68 90.23K
Q3 2021 share Increase +209.43% 55.5K shares 6.53M $113.21 82K
Q2 2021 share 0.00% 0 shares 529K $103.57 26.5K
Q1 2021 share 0.00% 0 shares -202K $83.64 26.5K
Q4 2020 share Decrease -85.99% -162.66K shares -12.68M $91.23 26.5K
Q3 2020 share 0.00% 0 shares 2.02M $79.82 189.16K
Q2 2020 share 0.00% 0 shares 1.18M $69.11 189.16K
Q1 2020 share Increase +262.63% 136.99K shares 7.83M $62.87 189.16K
Q4 2019 share Decrease -4.53% -2.47K shares 51K $77.76 52.16K
Q3 2019 share Decrease -8.01% -4.75K shares 347K $73.3 54.64K
Q2 2019 share Decrease -5.79% -3.64K shares -363K $61.58 59.4K
Q1 2019 share Increase +30.95% 14.90K shares 1.56M $63.78 63.04K
Q4 2018 share Increase +6.01% 2.73K shares -178K $51.06 48.14K
Q3 2018 share Increase +19.03% 7.26K shares 784K $58.03 45.41K
Q2 2018 share Decrease -36.26% -21.70K shares -932K $48.52 38.15K
Q1 2018 share Decrease -0.75% -450 shares 518K $46.51 59.86K
Q4 2017 share Decrease -0.64% -390 shares 54K $37.57 60.31K
Q3 2017 share Decrease -17.83% -13.17K shares -700K $36.44 60.70K
Q2 2017 share Decrease -20.88% -19.5K shares -16K $39.41 73.87K
Q1 2017 share Decrease -20.88% -24.63K shares -758K $31.36 93.37K
Q4 2016 share Increase +8.32% 9.06K shares -692K $31.23 118.01K
Q3 2016 share Increase +19.93% 18.10K shares 1.35M $40.19 108.94K
Q2 2016 share Increase +2556.32% 87.42K shares 2.9M $33.24 90.84K
Q1 2016 share Increase 0.00% 3.42K shares 120K $29.4 3.42K